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ABSTRACT
Besides controlling epithelial-to-mesenchymal tran-
sition (EMT) and cell invasion, the Snail1 transcrip-
tional factor also provides cells with cancer stem cell
features. Since telomere maintenance is essential for
stemness, we have examined the control of telomere
integrity by Snail1. Fluorescence in situ hybridiza-
tion (FISH) analysis indicates that Snail1-depleted
mouse mesenchymal stem cells (MSC) have both a
dramatic increase of telomere alterations and shorter
telomeres. Remarkably, Snail1-deficient MSC present
higher levels of both telomerase activity and the long
non-coding RNA called telomeric repeat-containing
RNA (TERRA), an RNA that controls telomere in-
tegrity. Accordingly, Snail1 expression downregu-
lates expression of the telomerase gene (TERT) as
well as of TERRA 2q, 11q and 18q. TERRA and TERT
are transiently downregulated during TGF-induced
EMT in NMuMG cells, correlating with Snail1 expres-
sion. Global transcriptome analysis indicates that
ectopic expression of TERRA affects the transcrip-
tion of some genes induced during EMT, such as
fibronectin, whereas that of TERT does not modify
those genes. We propose that Snail1 repression of
TERRA is required not only for telomere maintenance
but also for the expression of a subset of mesenchy-
mal genes.
INTRODUCTION
Telomeres are essential for genome integrity and protect
chromosome ends from being recognized as DNA double-
strand breaks (1). Telomere repeats are lost by attrition
during DNA replication due to the end-replication prob-
lem, and critically short telomeres elicit a DNA damage–
associated cell cycle arrest and replicative senescence (2–3).
Mammalian telomeres consist of TTAGGG DNA tandem
repeats and a six-subunit complex (TRF1, TRF2, TIN2,
TPP1, POT1 and Rap1), referred to as shelterin, that reg-
ulates telomere length maintenance and protects the ends
from being recognized as damaged DNA (4–5). Telomere
structure resembles constitutive heterochromatin as it also
contains the histone mark H3K9me3 and HP1 proteins,
which control chromatin architecture and are also involved
in telomere length maintenance and function (6–8). Alike
heterochromatin, telomeres are transcribed into telomeric
repeat-containing RNA (TERRA) molecules (9–10) that re-
main partly associated with telomeres and play crucial func-
tions (11). Recent work has suggested that TERRA RNAs
act as a scaffold, recruiting different factors to chromo-
some ends and controlling telomeric function in distinct
ways. TERRA promotes H3K9 trimethylation to control
heterochromatin formation (12–13), enhances recruitment
of chromatin modifiers to damaged telomeres (14–15), con-
tributes to telomere length regulation through the modu-
lation of exonuclease 1 and telomerase activities and par-
ticipates in capping chromosome ends (16–18). Recently,
TERRA has been found in extracellular fractions, suggest-
ing that it acts as a mechanism of communication between
telomeres and innate immune signals in tissue and tumor
microenvironments (19). TERRA is heterogeneous in size
and is transcribed by RNA polymerase II (RNA pol II)
(20) from CpG island-containing subtelomeric promoters,
located on average 1 kb upstream of TTAGGG repeats (10).
In mouse, the bulk of TERRA transcripts seems to be gen-
erated from a single subtelomere and associates in trans with
the remaining telomeres (15).
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Telomeres control tumor growth by limiting the number
of cell divisions, even in the presence of oncogenic muta-
tions. Short telomeres elicit permanent DNA damage re-
sponses that trigger cellular senescence, which is a powerful
anticancer barrier that suppresses unlimited proliferation in
many cells that lack telomerases (21). Therefore, stabiliza-
tion of telomere length is a key requirement for transformed
cells to achieve infinite proliferation potential during onco-
genesis, and it is obtained by activation of the telomerase
reverse transcriptase or the recombination-based ALT (al-
ternative lengthening of telomeres) mechanism (22). Telom-
erase is a ribonucleoprotein with a catalytic subunit prod-
uct of the TERT gene and a RNA template (TERC) re-
quired for reverse transcription (23). Although TERT ex-
pression can also be controlled through differential splicing
(24,25), transcriptional repression of TERT limits telom-
erase activity in somatic cells (26). The increased expres-
sion of telomerase in many cancer cells is often due to mu-
tations in the TERT promoter, indicating a necessary up-
regulation of TERT during tumor progression (27–29). Fi-
nally, TERT transcription is also activated in human cells
with short telomeres due to the loss of repressive chromatin
loops (30). The presence of these short telomeres has also
been associated to increased chr5p TERRA expression (30).
Epithelial-to-mesenchymal transition (EMT) plays an
important role in the progression of primary epithelial tu-
mors (31). During EMT, epithelial cells lose their epithe-
lial characteristics, including adherens junctions and apical-
basal polarity, and acquire a mesenchymal phenotype and
the ability to migrate and invade (32,33). The Snail1 tran-
scription factor plays a key role in initiating the EMT pro-
cess (34). Snail1 is rapidly induced by cytokines or by stress
conditions that trigger EMT, and it binds and represses the
expression of E-cadherin and other epithelial genes (34,35).
Moreover, acting through the co-repressor LOXL2, Snail1
controls transcription of major satellite transcription and
heterochromatin during EMT (36). Snail1 also participates
in the activation of mesenchymal genes, such as fibronectin
(37,38). Likely related to this, Snail1 is also required for
fibroblast activation; the absence of this factor prevents
induction of markers of active fibroblasts by TGF- or
other factors (39). Moreover, Snail1 expression in cancer-
associated fibroblasts is also required for their role stimu-
lating epithelial tumor cell invasion (39).
Besides inducing migratory and invasive properties, EMT
provides cells with other features, such as a higher resistance
to apoptosis and immunosuppression (31), and even gener-
ates cells with properties of stem cells (40,41). Indeed, trans-
fection of Snail1 or Twist to immortalized human mam-
mary cells confers them with the capability to form mam-
mospheres, a property associated to the acquisition of stem
cell characteristics (40). Since stemness requires the capa-
bility to maintain telomere length, we have now examined
the action of Snail1 on these structures. Here, we report
the identification of a new role for Snail1 transcription fac-
tor regulating TERT and TERRA transcription and telom-
ere integrity. Our results reveal that Snail1 repression of
TERRA is required for expression of a subset of mesenchy-
mal genes as well as for EMT completion.
MATERIALS AND METHODS
Cell lines, transfection and infection
Cells were maintained in Dulbecco’s modified Eagle’s
medium (Invitrogen) supplemented with 10% fetal bovine
serum (Invitrogen) at 37◦C in 5% CO2. NMuMG cells
were also supplemented with insulin (10 mg/ml). TGF
(5 ng/ml) was used to induce EMT in NMuMG cells.
MSCs were obtained from a conditional knockout mouse
(Snail1Flox/Flox) (42,43), and Snail1 deletion was induced by
transfection with pcDNA3-Cre or (as control) pcDNA3-
GFP. RWP-1 cells transfected with empty plasmid or
with pcDNA3-Snail1 (44), murine embryonic fibroblasts
(MEFs) or cancer associated fibroblasts (CAFs) depleted
of the Snail1 gene (36,39), and HCT75 cells (45) were gen-
erated as previously described. NMuMG cells were infected
with retroviruses using pLU-Flag-VP16-TRF1N, pLU-
Flag VP16 or pLU-Flag-TRF1N vectors and selected
with puromycin (1 g/ml) to overexpress TERRA (19).
To overexpress murine Tert in NMuMG cells, retroviral
viruses were generated using Plat-E Retroviral Packaging
Cell Line. Plat-E were transfected (day 0) using Lipofec-
tamine 2000 reagent (Invitrogen) either with pBabe-mTert
or pBabe-empty vectors. The transfection medium was re-
placed with fresh medium after 24 h (day 1), and the cell-
conditioned medium at days 2 and 3 was filtered and used
to infect NMuMG cells with 8 mg/ml polybrene. Infected
NMuMG cells were then incubated with fresh medium for
a further 24 h and then selected with puromycin (1 g/ml).
Downregulation of Snail1 in NMuMG cells was performed
by transfecting control or Snail1-specific siRNA as previ-
ously described (36).
PNA-FISH of prometaphase spreads
For prometaphase spread analysis, MSC were incubated
with colcemide (0.5 mg/ml) for 90 min, collected by
trypsinization, swollen in hypotonic buffer for 10 min at
37◦C and then fixed and processed as described previ-
ously (46). Chromosomes were hybridized with 0.5 g/ml
of a Cy3-conjugated (CCCTAA)3 PNA telomere repeat
probe (Applied Biosystems) and stained with DAPI (0.2
g/ml). Images were acquired using a fluorescent micro-
scope (Olympus BX61) and processed and merged us-
ing ImageJ software. For Q-FISH analysis, images were
processed using TFL-Telo software (kindly provided by
P. Lansdorp, Terry Fox Laboratory, Vancouver, Canada).
Analyses were performed as a blind study as described pre-
viously (47).
Immunofluorescence/PNA-FISH analysis
(IF)-FISH staining was performed as previously described
(48). Briefly, cells were blocked in 1% bovine serum albu-
min in PBS, followed by incubation with primary mouse
-H2AX (1.5 mg/ml) (Upstate Millipore 05-636) and
secondary FITC -mouse (Jackson Laboratories) anti-
bodies. Coverslips were washed with PBS, fixed in 2%
paraformaldehyde in PBS for 5 min and then washed six
times in PBS for 10 min. The samples were dehydrated (us-
ing a 70%, 95% and 100% ethanol series for 5 min), air dried
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and incubated in denaturing solution (70% formamide/2×
SSC) for 10 min at 75◦C. Chromosomes were hybridized
with 0.5 g/ml of a Cy3-conjugated (TTAGGG)3 PNA
telomere repeat probe (Applied Biosystems) in hybridizing
solution for 5 min at 85◦C, followed by a 2-h incubation
at room temperature. Preparations were then washed twice
for 15 min each with 70% formamide in 10 mM Tris (pH
7.2), washed with PBS and stained with DAPI (0.2 g/ml).
Images were acquired using a fluorescent microscope (Ax-
ioplan 2, Carl Zeiss, Inc.) and processed using Openlab soft-
ware (Perkin Elmer).
Telomeric repeat amplification protocol (TRAP) assay.
Quantitative measurement of telomerase activity was per-
formed using the TRAPeze RT Telomerase detection kit
(Millipore) according to the manufacturer’s instructions.
Briefly, the cells were lysed on ice for 30 min in CHAPS
buffer and then centrifuged at 12 000 g for 20 min at 4◦C.
The supernatant was collected, and the protein concentra-
tions were determined by BCA protein assay. Each PCR re-
action used 200 ng of total protein extract. PCR products
were separated in a 12.5% non-denaturing polyacrylamide
gel. Images were quantified with ImageJ software.
Chromatin immunoprecipitation (ChIP)
ChiP experiments were performed as described previously
(36). Briefly, cells were crosslinked in 1% formaldehyde for
10 min at 37◦C. Crosslinking was stopped by adding glycine
to a final concentration of 0.125 M for 2 min at room tem-
perature. Cell monolayers were scraped in cold soft lysis
buffer (50 mM Tris, pH 8, 10 mM EDTA, 0.1% NP-40 and
10% glycerol) and incubated 20 min on ice. Nuclei pellets
were lysed with SDS lysis buffer (1% SDS, 10 mM EDTA
and 50 mM Tris, pH 8). Extract was sonicated to gener-
ate 200 to 500 bp DNA fragments. Protein (1 mg) was di-
luted 1:10 with dilution buffer (0.01% SDS, 1.1% Triton
X-100, 1.2 mM EDTA, 16.7 mM Tris pH 8 and 167 mM
NaCl) and precleared by incubating with 30 l of protein
A or protein G magnetic beads (Millipore) and 5 g of ir-
relevant immunoglobulin G at 4◦C for 3 h. Samples were
immunoprecipitated with the primary antibody (mouse -
Snail1 (36), -p53 (Santa Cruz, SC-6243) or -myc (ATCC
9E10); an irrelevant G immunoglobulin was used as con-
trol. After incubating on a rotating wheel at 4◦C overnight,
the antibody-chromatin complexes were rescued by incu-
bating with 20 l pre-blocked protein G magnetic beads
at 4◦C for 3 h. The beads were then washed with the fol-
lowing buffers (four times each): low-salt washing buffer
(20 mM Tris–HCl pH 8, 5 mM NaCl, 2 mM EDTA 0.1%
SDS, 1% Triton X-100), high-salt washing buffer (20 mM
Tris–HCl pH 8, 150 mM NaCl, 2 mM EDTA 0.1% SDS,
1% Triton X-100) and LiCl buffer (10 mM Tris–HCl pH 8,
1 mM EDTA, 250 mM LiCl, 15% NP-40, 1% sodium de-
oxycholate). Chromatin was eluted from beads by adding
100 l elution buffer (1% SDS, 0.1 M Na2CO3) and shak-
ing at 37◦C for 1 h. The eluted samples were de-crosslinked
by adding NaCl at 200 mM final concentration and incu-
bated at 65◦C overnight. The day after, the proteins com-
plexes were treated with proteinase K solution (10 l 0.5 M
EDTA, 20 l 1 M Tris, pH 6.5 and 40 g proteinase K) and
incubated 1 h at 55◦C. DNA was purified with the Qiagen
PCR Purification kit, eluted in water and analyzed by RT-
qPCR.
RNA extraction and analysis. RNA extraction was per-
formed using TRIzol (Invitrogen), and samples were treated
with DNase Turbo (Ambion) to eliminate DNA contam-
ination. One g of total RNA was retro-transcribed with
Transcriptor First Strand cDNA Synthesis Kit (Roche) at
65◦C for 10 min using random hexamers as primers. When
amplifying human TERRAs, retrotranscription was carried
out using a C-strand telomeric oligonucleotide consisting of
five CCCTAA repeats. A control retrotranscription reaction
without enzyme was performed when required. Real-time
PCR was performed with SYBR Green I Master Reagent
using a LightCycler 480 Real-Time PCR machine (Roche)
with the following conditions: 40 cycles amplification, 94◦C
for 30 s, 60◦C for 15 s, 72◦C for 10 s. Oligonucleotides se-
quences are indicated in Supplementary Table S1. Relative
quantification for the studied genes was calculated using
Light Cycler 480 Software 1.5.0 by the Ct method, using
Pumilio or Gapdh as controls.
TERRA RNA was also determined by dot blot analy-
sis. Five g RNA were resuspended in 1 mM EDTA (pH
8.0) to a final volume of 50 l, mixed with denaturing solu-
tion (30 l 20 × SSC and 20 l 37% formaldehyde), incu-
bated at 65◦C for 30 min and then immediately cooled down
on ice. The RNA was spotted on a Hybond-N membrane
(Amersham) using a dot blot apparatus. The membrane was
then UV cross-linked at 125 mJ in UV Stratalinker 2400
(Stratagene) and pre-hybridized in Church buffer (0.5 N
Na-phosphate, pH 7.2, 7% SDS, 1 mM EDTA, 1% BSA) at
55◦C for 2 h. After addition of the 32P-labeled (TAACCC)4
probe, the sample was incubated overnight at 55◦C. The blot
was washed twice in wash buffer 1 (0.2 N Na-phosphate,
2% SDS, and 1 mM EDTA at room temperature) and once
in wash buffer 2 (0.1 N Na-phosphate, 2% SDS and 1 mM
EDTA) at 50◦C. Radioactive signals were collected with a
phosphorimaging screen, and the signal was measured us-
ing a Typhoon 9410 Imager (GE Healthcare). A 18s rRNA
probe (5′-CCATCCAATCGGTAGTAGCG-3′) was 5′ end-
labeled with 32P using T4 Polynucleotide Kinase (New Eng-
land Biolabs); this was used as an internal control.
RNA-seq analysis
RNA was isolated with Gene Elute Mammal Total RNA
Miniprep Kit (Sigma), and its integrity was analyzed by
electropherogram (Agilent Technologies). mRNA libraries
were prepared with the rRNA depletion protocol and se-
quenced on an Illumina HiSeq2500 with a read length of
50 bases. Quality check was performed using tool FastQC.
Reads were aligned with STAR (Spliced Transcripts Align-
ment to a Reference) to release 86 of the Mus musculus
ENSEMBL version of the genome (GRMm38/mm10 as-
sembly). HTSeq-count tool from HTSeq package was used
to count the number of reads mapping each gene. DESeq2
method was used for analyzing differential gene expression
of count data.
Additional methods are provided in the Supplemental In-
formation.
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Figure 1. Snail1 loss causes telomere dysfunctions. (A) Expression of Snail1 at late passages (PD 146) of control MSC (CT) or MSC depleted of the Snail1
gene (Snail1 KO) as shown by RT-qPCR (left) and western blot (right). (B) A metaphase spread from Snail1 KO MSC showing telomere alterations (SFE,
signal-free ends; SA, sister associations). Telomeres were stained with a Cy3-labeled PNA telomere probe (red). (C and D) Frequency of telomere alterations
observed in control (CT) and Snail1 KO MSC. N indicates the number of chromosomes analyzed. The mean ± SEM of three independent experiments is
shown. *P < 0.05.
RESULTS
Snail1 is essential for telomere maintenance in mouse mes-
enchymal stem cells
We initially studied the contribution of Snail1 to telomeric
integrity using mouse MSC derived from the bone marrow
of Snail1-conditional mice (Snail1Flox/Flox) (43). Snail1 was
efficiently ablated by Cre-mediated recombination to gen-
erate the Snail1 knockout (KO) subline, as shown by analy-
sis of mRNA levels and by western blot (Figure 1A). These
cells grew slightly slower than control MSC, with no evi-
dence of apoptosis (43); consequently, they could be main-
tained for at least 150 population doublings (PDs). Telom-
ere integrity of MSC metaphase spreads was analyzed by
FISH at 146 PD using a specific PNA probe for telom-
eric TTAGGG repeat (Figure 1B). We observed that Snail1
KO MSC presented chromatids lacking telomeric signal
(signal-free ends [SFE]) as well as chromatids with fused
sister telomeres (sister association [SA]) in 24% and 16% of
the analyzed chromosomes, respectively. In contrast, only
a small fraction of control cells (Snail1 CT) displayed these
telomeric alterations (2.4% for SFE, and 5.8% for SA) (Fig-
ure 1C and D). The averages for SFE and SA were also sig-
nificantly higher in Snail 1 KO mouse embryonic fibroblasts
(MEFs) as compared to that of the controls (Supplemen-
tary Figure S1A).
To determine if the telomere alterations observed in the
Snail1 KO cells affect telomere extension, we analyzed the
telomere length in these cells. MSC at metaphase were ana-
lyzed by quantitative fluorescence in situ hybridization (Q-
FISH) at late passages after Snail1 depletion. Analysis of
fluorescence intensities (Figure 2A–C) revealed that Snail1
KO MSC had shorter telomeres than control cells, indi-
cating a positive role of Snail1 on telomere length. These
results were also reproduced in MEFs, in which absence
of Snail1 led to decreased telomere length (Supplementary
Figure S1B).
To verify these observations, telomere length was mea-
sured in the human HCT75 cell line at different passages
with the telomeric terminal restriction fragment (TRF) as-
say. HCT75 is a clonal derivative of the human fibrosar-
coma HT1080 cell line, which maintains its telomeres at
a constant length. We generated stable cell lines express-
ing Snail1-HA, either wild-type (Snail1-HA) or with Pro2
mutated to Ala (Snail1 P2A-HA), which binds DNA but
cannot repress transcription (34). Cell lines were analyzed
at early PD (PD2–4) and late PD (PD64–68) stages. Im-
munoblot analysis confirmed that the cells stably expressed
Snail1 (Supplementary Figure S2A). TRF assays indicated
that Snail1 expression promoted an increase in telomere
length when cells were passaged (Supplementary Figure
S2B and C). This lengthening was not observed in the con-
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Figure 2. Snail1 regulates telomere length in MSC. (A) Representative metaphase spreads at late passages (PD 146) of Snail1 control MSC (CT) or Snail1
KO MSC. Telomeres were stained with a Cy3-labeled PNA telomere probe. (B) Q-FISH analysis showing the distribution of telomere fluorescent intensity
in metaphase chromosomes from MSC. Data were accumulated using 40 metaphases for each histogram. Telomere intensity is expressed with arbitrary
units; the average is indicated for each histogram. (C) Quantification of (B) from three independent Q-FISH analyses. *P < 0.05.
trol cells or in cells over-expressing the transcriptionally-
inactive form of Snail1P2A. Thus, Snail1 transcriptional re-
pressive activity is required for its effect on telomere elon-
gation.
Snail1 regulates Tert expression in MSC
As telomere maintenance is greatly dependent on Tert ex-
pression, we next characterized the role of Snail1 in regulat-
ing the expression of this enzyme in mouse MSC. Although
Snail1 KO MSC exhibited shorter telomeres (see Figure 2B
and C), these cells displayed a 2-fold increase in the lev-
els of Tert RNA with respect to the control (Figure 3A).
In contrast, the levels of the telomerase RNA component,
Terc, were not significantly different in Snail1 KO cells ver-
sus the control (Supplementary Figure S3). When Snail1
expression was rescued in the KO cells by stable transfec-
tion, the levels of Tert RNA were downregulated (Figure
3A). Up-regulation of Tert in MSC Snail1 KO was further
confirmed by quantification of telomerase activity in cell ex-
tracts using the TRAP assay (Figure 3B and C). Also in this
case, transfection of Snail1 repressed the telomerase activity
(Figure 3B and C). Transcription of TERT was also con-
trolled by Snail1 in the human cell line RWP-1, in which
Snail1 overexpression down-regulated TERT RNA levels
(Figure 3D). Snail1 up-regulates Zeb transcriptional repres-
sors and cooperates with them in E-cadherin gene (CDH1)
repression (49). Indeed, ZEB1 RNA was upregulated by
ectopic Snail1 expression in RWP-1 cells (Figure 3D) and
both Zeb1 and Zeb2 potently downregulated TERT levels
when over-expressed in these cells (Figure 3D).
Regulation of Tert transcription by Snail1 was also veri-
fied by luciferase assays using a –599/+53 fragment of the
mouse Tert promoter cloned in pGL3 plasmid. MSC Snail1
KO exhibited an increased activity of the Tert promoter with
respect to the control; ectopic transfection of Snail1 in these
cells repressed this activity (Figure 3E). As expected, the
Snail1 P2A repression-deficient mutant did not affect the
Tert promoter. A similar decrease of Tert promoter activity
was also observed in RWP-1 cells after Snail1 expression,
using as control the CDH1 promoter, a well-known Snail1-
repressed gene (34) (Figure 3F). E-boxes corresponding to
putative Snail1 binding elements were identified in the Tert
promoter at –253 and –123 with respect to the transcrip-
tion start site, as well as more 3′ downstream, at +301, +324
and +426. ChIP assays confirmed that Snail1 binds to –
220/+26 and +243/+451 sequences in control MSC, while
no binding was observed when an irrelevant IgG was used
as a negative control or in MSC Snail1 KO (Figure 3G).
Zeb1-inhibition of Tert expression (see above) was also as-
sociated with binding to the Tert promoter (Figure 3G).
Finally, we interrogated the RNA public databases from
different tumors for the expression of TERT and its in-
hibitors. TERT RNA expression inversely correlated with
that of SNAIL1 in pancreatic adenocarcinoma or liver
hepatocellular carcinoma, with ZEB1 in pancreatic, pro-
static and colorectal adenocarcinomas, and in serus ovar-
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Figure 3. Snail1 regulates Tert RNA expression and telomerase activity. (A) Western blot for Snail1 (upper panel) and RT-qPCR for Tert RNA (lower
panel) in control MSC (CT), Snail1 KO and Snail1 KO after Snail1 rescue. *P < 0.05. (B) Representative image of a TRAP assay in MSC. PCR products
were separated by 12.5% non-denaturing polyacrylamide gel electrophoresis. Activity was determined in control MSC, Snail1 KO and Snail1 KO after
Snail1-HA transfection. (C) Quantification of three independent TRAP assays. *P < 0.05. (D) RT-qPCR analysis of Snail1 (1st left panel), Zeb1 (2nd left
panel), Zeb2 (3rd left panel) or Tert RNA (right panel) in RWP-1 cells transfected with Snail1, Zeb1 or Zeb2 cDNA in eukaryotic expression plasmids.
*P < 0.05. (E, F) Luciferase assays showing the activity of the Tert promoter (–599 to +53 promoter fragment cloned in pGL3) in MSC (E) or RWP-1
(F) cells. Cells were transfected with control, wild-type Snail1-HA or the Snail1 P2A mutant, as indicated. The CDH1 promoter activity was also assayed
in (F). Data represent the mean ± SEM of three independent experiments. **P < 0.01; *P < 0.05. (G) ChIPs were performed using -Snail1 antibody in
CT and Snail1 KO MSC (left), or with -myc antibody in CT cells or cells overexpressing ectopic myc-ZEB1 (right). Different fragments (F1 and F2) of
the Tert promoter were amplified by RT-qPCR. An irrelevant IgG was used as a negative control in the same regions, whose values are set as 1 (left); the
control corresponding to the value obtained with -myc antibody in non-transfected cells is shown in the right panel.
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Figure 4. Telomeric transcription is repressed by Snail1. (A) RT-qPCR showing the changes in expression of TERRA transcripts from different chromo-
somes (chr2q, chr11q or chr18q) in control MSC, Snail1KO MSC or Snail1KO+Snail1-HA MSC. Data represent the mean ± SEM of three independent
experiments. *P < 0.05; **P < 0.01. (B, C) Levels of Snail1 and chr18q TERRA (B) or h2q and hXqY TERRA (C) were assessed by RT-qPCR in CAFs
control (CT) and Snail1 KO (B) or in RWP-1 cells stably expressing Snail1-HA (C). **P < 0.01; *P < 0.05; P values higher than 0.05 are indicated.
ian cancer and head and neck ovarian carcinomas, and with
ZEB2 in hepatocellular and prostate carcinomas and in
serus ovarian cancer (Supplementary Figure S4). Taken to-
gether, these data demonstrate that Snail1 transcriptionally
represses Tert RNA, either directly or by inducing the ex-
pression of Zeb proteins.
Snail1 inhibits telomeric transcription
Although we observed that cells deficient for Snail1 had
shorter telomeres, the presence of Snail1 did not increase
but rather repressed telomerase transcription (see above).
These results suggested that Snail1 regulates telomere main-
tenance by controlling mechanisms other than telomerase
expression. Therefore, we next investigated a possible role
of Snail1 in the regulation of telomere transcription. Telom-
eres are transcribed into telomeric repeat-containing RNAs
(TERRA), large non-coding RNAs that form an inte-
gral part of telomeric heterochromatin. TERRA upreg-
ulation causes telomere shortening (16,50). We analyzed
TERRA transcription by quantitative RT-qPCR, using sets
of primers mapped to the subtelomeric region of different
mouse chromosomes (chr2q, chr11q, chr18q). We observed
a significant increase in the TERRA transcripts in the
Snail1 KO MSC as compared to control cells, with chr18q
TERRA presenting the highest Snail1-depending expres-
sion (Figure 4A). Accordingly, TERRA transcripts were
downregulated after Snail1 ectopic expression in Snail1 KO
MSC (Figure 4A). Similar results were obtained when we
analyzed TERRA levels in CAFs obtained from murine
tumors (39). Depleting Snail1 from these CAFs increased
TERRA levels (Figure 4B), confirming a repressive role of
Snail1 in telomere transcription. Moreover, an analysis in
human cells showed that overexpression of Snail1 in the hu-
man RWP1 cell line downregulated TERRA h2q and hXqY
(Figure 4C).
TERRA downregulation during EMT is required for upregu-
lation of a subset of mesenchymal genes
As Snail1 plays a key role in EMT, we next analyzed the
levels of TERRA in the murine mammary gland NMuMG
epithelial cell line treated with TGF, a widely used in
vitro model of EMT. Addition of this cytokine induced
Snail1 upregulation that preceded the expression of mes-
enchymal genes, such as fibronectin, and the silencing of
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Figure 5. Telomeric transcription is downregulated during EMT.(A–D) Expression levels of Snail1, fibronectin, E-cadherin and p53 during TGF-induced
EMT in NMuMG was assessed by RT-qPCR (A) and western blot (B). Levels of TERRA transcripts (from chr2q, chr11q and chr18q) (C), Tert and Terc
(D) were determined by RT-qPCR during TGF-induced EMT in NMuMG cells. Data represent the mean ± SEM of three independent experiments. **P
< 0.01; *P < 0.05. (E) NMuMG cells exposed to TGF were analyzed by ChIP with a p53-specific antibody. ChIP was quantified by qPCR with primers
that anneal to the promoter of the murine chr18q-TERRA; a region downstream the TERRA transcript with no described promoter activity was used as a
negative control. Data represent the mean ± SEM of three independent experiments. *P < 0.05. (F) TERRA and Tert levels in Snail1-deficient NMuMG
cells. Snail1 was downregulated in NMuMG cells by transfection of a small interfering RNA (siSnail1) as indicated in Methods. A non-relevant siRNA
was used as control (siCT). Levels of chr18q TERRA, Tert and Snail1 transcripts were determined by RT-qPCR during TGF-induced EMT in NMuMG
cells. *P < 0.05.
154 Nucleic Acids Research, 2018, Vol. 46, No. 1
Figure 6. Downregulation of TERRA during EMT correlates with telom-
ere deprotection. (A) NMuMG cells were treated with TGF (for 0, 2,
8, or 24 h) to induce EMT. Representative images of NMuMG stained
with -H2AX (green) and processed for FISH with a Cy3-conjugated
(TTAGGG)3 probe (red) are shown. Co-localizing events (arrowheads) in-
dicate telomere dysfunction-induced foci (TIFs). (B) Quantification of the
frequency of cells with > 2 TIFs/nuclei. Between 250 and 300 cells were
analyzed in each time point. The value corresponds to the average of three
experiments. **P < 0.01; *P < 0.05.
E-cadherin (Cdh1) (Figure 5A and B). TERRA transcrip-
tion was significantly decreased after 2 h of TGF expo-
sure (Figure 5C), concomitantly with Snail1 upregulation.
TERRA downregulation was transient, and TERRA lev-
els after 24 h were equivalent to untreated control cells. In
line with its regulation by Snail1, Tert RNA also decreased
during TGF-induced EMT, reaching a minimal level af-
ter 2 h, whereas the Terc transcript did not change signifi-
cantly (Figure 5D). TERRA expression is controlled by p53
(51), a protein whose function is antagonized by Snail1 (52).
Since p53 activates TERRA transcription by direct binding
to subtelomeric sequences (51), we determined whether p53
binding to the chr18q subtelomeric promoter was modu-
lated during EMT. While p53 levels were not significantly
altered during EMT (Figure 5B), its binding to the chr18q
promoter was downregulated 2 h after TGF addition (Fig-
ure 5E), concomitant with Snail1 upregulation (Figure 5B).
The relevance of Snail1 expression for the TERRA tran-
sient inhibition during EMT was also demonstrated by
RNA interference experiments. Downregulation of Snail1
in NMuMG cells by transfecting a specific siRNA pre-
vented the TERRA decrease caused by TGF after 2 h of
TGF exposure (Figure 5F). Tert RNA was also signifi-
cantly less inhibited by TGF in Snail1-deficient cells than
in controls (Figure 5F).
Reduction of chr18q TERRA increases the number
of telomere dysfunction–induced foci (TIFs) (15). Since
chr18q TERRA is downregulated during EMT, we deter-
mined the presence of TIFs in NMuMG cells during this
transition by analyzing the presence of the H2AX DNA
damage marker at the telomeres (53). After 2 h of TGF
exposure, and in parallel with Snail1 induction and chr18q
TERRA downregulation, we observed a significant increase
in the number of cells with two or more TIFs (Figure 6A and
B). Following an inverse pattern over time as compared to
TERRA, the number of TIF-positive cells was downregu-
lated at later time points (Figure 6B).
To determine whether TERRA downregulation is func-
tionally important for EMT, we engineered NMuMG cells
to produce elevated TERRA levels. We used the strat-
egy developed by Lieberman and co-workers who trans-
duced a mutant form of the telomere-binding factor TRF1
(TRF1N) alone or fused to the VP16 transcriptional
activation domain (VP16-TRF1N) (19). Stable expres-
sion of these proteins was confirmed by western blot (Fig-
ure 7A), and upregulation of TERRA was validated by
RNA dot blot (Figure 7B). Although TERRA upregula-
tion did not modify morphology, migration or invasion of
NMuMG cells after TGF-mediated EMT (Supplemen-
tary Figure S5), the transcription of EMT-related genes
(such as that of fibronectin) was affected (Figure 7E).
We compared the global transcriptomes of NMuMG con-
trol cells (TRF1N) to those of cells that overexpressed
TERRA (VP16-TRF1N) following a 24-h treatment with
TGF. RNA-seq analysis revealed that 1,508 genes were
differentially regulated by TGF in cells after overexpress-
ing TERRA with respect to control cells (Supplementary
Table S2). Most of these genes are mesenchymal genes that
were less stimulated by TGF when TERRA was present,
and that are associated with pathways such as cell prolifera-
tion, cell migration, apoptosis, angiogenesis, cellular move-
ment and extracellular matrix organization (Figure 7C).
We also determined the relative expression of several genes
classically associated with EMT (Figure 7D). Changes in
the expression of several of these genes were validated by
RT-qPCR (Figure 7E and Supplementary Figure S6). Fi-
bronectin, Jag1, Loxl1, Fgfr1 and Pdgfrβ RNAs exhibited
a lower upregulation by TGF in TERRA-expressing cells
than in control cells. Expression of these genes was not af-
fected by transfection of VP16 alone (Supplementary Fig-
ure S7). Regulation of other EMT-relevant genes, such as
E-cadherin, Snail1 or Vimentin, was not significantly al-
tered by TERRA over-expression (Figure 7E). NMuMG
cells were also stably transduced with murine Tert cDNA
in an expression plasmid, and the expression of TERRA-
sensitive genes was also determined after TGF-induced
EMT. None of the analyzed genes was expressed differently
in cells with Tert as compared to control cells (Supplemen-
tary Figure S8).
DISCUSSION
In primary epithelial cells, chromosomes with short telom-
eres are more frequently involved in missegregation events
than chromosomes with normal telomere lengths (54).
Shortened telomeres have been linked to chromosome in-
stability in the setting of age-related diseases associated with
genetic disruption and carcinogenesis (55). Critically short
telomeres expose chromosomal ends, engage the DNA
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Figure 7. Ectopic TERRA expression alters the EMT gene profile. (A) Western blot of NMuMG cells transduced with Flag-TRF1N alone or fused with
the transcriptional activator VP16. (B) Radioactive RNA dot blot for TERRA from NMuMG cells transduced with TRF1N or VP16-TRF1N. 18S
served as a loading control. Samples treated with RNase A were used as negative controls. (C) Gene ontology analysis of differentially expressed genes in
VP16-TRF1N NMuMG cells as compared to control TRF1N NMuMG cells after TGF treatment (24 h). The global transcriptome was analyzed
by RNA-seq. (D) Short list of relevant EMT-related genes and their expression in VP16-TRF1N-NMuMG cells as compared to control NMuMG at 24
h after TGF treatment. Log2 fold-changes are indicated. A more extended list of transcripts is available in Supplementary Table S2. (E) RT-qPCR was
used to determine the expression of the selected EMT-related genes at 24 h after TGF treatment (except for Snail1 at 2 h). Data represent the mean ±
SEM of three independent experiments. *P < 0.05.
damage response and precipitate end-to-end fusions and
recombination events (SFE and SA). We show here that
Snail1 depletion leads to telomere abnormalities in mes-
enchymal cells, in line with the described action of Snail1
inducing stemness properties (40). In contrast to our expec-
tations, however, we observed that Snail1 represses rather
than activates TERT expression; this effect has also been re-
ported by others (56). Indeed, not only Snail1 but also other
transcriptional factors involved in EMT, such as Zeb1,
also inhibit Tert. Accordingly, Tert is downregulated during
EMT. The precise functional outcome of this decrease is still
unknown; it is possible that it is related to the non-canonical
actions described for telomerase in controlling NFkB tran-
scriptional activity (57).
Snail1 also represses the expression of TERRA tran-
scripts. We suggest that the altered telomeres observed after
Snail1 depletion are a consequence of the excessive levels of
TERRA in these cells. Although the function of TERRA is
not fully understood, the emerging view is that it acts as a
molecular scaffold for proteins required for proper telomere
function. Several findings indicate that telomere transcrip-
tion controls telomere structure and function (13). Cells
from the human pathology ICF (immunodeficiency, cen-
tromeric region instability, facial anomalies syndrome) have
hypomethylated subtelomeric regions, abnormally elevated
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TERRA levels, shortened telomeres and associated telom-
ere aberrations (such as SFE), but unaltered telomerase lev-
els (58). In fact, it has been previously suggested that up-
regulated TERRA transcription leads to several forms of
telomeric aberrations (including SFEs and SA), heterochro-
matin reorganization and telomere shortening (9,59). Some
authors suggest that TERRA acts as direct inhibitor of
telomerase activity (60); accordingly, TERRA ectopic ex-
pression decreases telomerase activity (61). It is also possi-
ble that TERRA-induced telomere shortening is indepen-
dent of telomerase, since it has been reported to also act on
exonuclease 1 (16).
How telomere transcription is controlled is still largely
unknown, but transcription regulators of telomeres include
the CTCF and ATRX chromatin remodelers, as well as the
Rad21 cohesin subunit (62–64). Recently, the nuclear res-
piratory factor 1 (NRF1) has also been identified as a new
activator of human telomere transcription, revealing a new
link between telomeres and metabolism (65). A recent re-
port has shown that 15q TERRA transcription is activated
by Rb by its direct binding to this promoter (66). A similar
activation of TERRA expression has been described for p53
related to its ability to prevent TIFs (51). Interestingly, p53
and Snail1 are mutually antagonistic, and Snail1 prevents
p53 from functioning in distinct systems (44,52,67–69). Al-
though this interference is general, the molecular mecha-
nism might be cell-specific, since it is associated with p53
degradation in some systems (52), an effect that we how-
ever have not observed. We have not detected Snail1 bind-
ing to the TERRA subtelomeric promoter, suggesting that
Snail1’s action on p53 is likely due to p53 inactivation, per-
haps through covalent modification of p53 itself or the re-
pression of an essential p53 cofactor. In any case, our results
suggest that TERRA is another locus inversely regulated by
Snail1 and p53.
The role of TERRA was investigated during EMT in the
widely-used model of NMuMG cells treated with TGF.
Telomere transcription is transiently downregulated at 2
h after exposure to this cytokine, correlating with the up-
regulation of Snail1 and prior to the expression of most
mesenchymal genes (Figure 5). Simultaneously, TGF also
promotes an increase in the number of cells displaying
TIFs, suggesting that telomeres are deprotected but are
still long (Figure 6). TIFs are a consequence of activation
of DNA-damage response at chromosome ends, originated
by TERRA downregulation (15,53). Although TERRA
chr18q seems to be the main transcript responsible for
this regulation (15), other telomeric transcripts, such as
TERRA 2q and 11q, might also contribute to deprotection,
since they are also transiently downregulated during EMT,
similar to TERRA chr18q. An interesting question remain-
ing to be investigated consists in determining the relevance
of these TIFs in EMT. It is possible that this transient re-
sponse is required to activate mesenchymal genes; alterna-
tively, it might correspond to a transient lesion caused by
telomere deprotection, necessary for the chromosome reor-
ganization taking place during EMT.
Our results confirm and extend previous observations in-
dicating that Snail1 regulates pericentromeric heterochro-
matin transcription (36). Snail1 repression of pericen-
tromeric major satellite RNA also takes place early dur-
ing EMT and is required for the completion of the pro-
cess. Compared with major satellite, upregulation of ectopic
TERRA had a reduced impact on EMT, with no changes
visible for cell migration or invasion with respect to con-
trol cells. It is likely that the global contribution of TERRA
is lower than that of major satellite in the cellular organi-
zation of heterochromatin; therefore, it would be expected
that it would also have a lesser role in the proposed chromo-
some repositioning that takes place during this transition
(36). Accordingly, we did not detect alterations in essential
transcriptional factors, such as Zeb1 and Zeb2, in contrast
to what we observed with overexpressed major satellite (36).
In any case, global transcriptome analysis indicated that ec-
topic TERRA expression prevented the transcription of a
subset of EMT-related genes. Several questions now remain
to be addressed, such as what are the functions of these
genes, and whether their lower levels of expression prevent
some other actions of mesenchymal cells, such as commu-
nication with tumoral cells or other roles from the stroma.
As a final point, our results reveal a novel connection be-
tween EMT and stemness. Several transcriptional factors
involved in EMT, such as Twist and Zeb1, also inhibit cell
senescence (70). We now show that the Snail1 transcription
factor, the key regulator of EMT, not only affects cell inva-
sion, resistance to apoptosis and metabolic reprogramming
(31,34,44,71–73) but also is essential for telomere mainte-
nance and integrity. This multiple function in tumorigen-
esis might open new strategic therapeutic opportunities to
develop Snail1-inhibitory drugs for fighting tumor cells.
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